WordNet

a disorder (usually of unknown origin) of the heart muscle (myocardium) (同)myocardiopathy

PrepTutorEJDIC

tantalumの化学記号

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. ストレス（たこつぼ型）心筋症 stress takotsubo cardiomyopathy
2. 拡張型心筋症の原因 causes of dilated cardiomyopathy
3. 女性における冠動脈疾患の臨床的特徴および診断 clinical features and diagnosis of coronary heart disease in women
4. 心筋症の定義および分類 definition and classification of the cardiomyopathies
5. 急性心筋梗塞における心原性ショックの臨床症状および診断 clinical manifestations and diagnosis of cardiogenic shock in acute myocardial infarction

English Journal

Brain natriuretic peptide: a biomarker for all cardiac disease?

Mahadavan G, Nguyen TH, Horowitz JD.Author information The Queen Elizabeth Hospital, Department of Cardiology, Basil Hetzel Institute, The University of Adelaide, Australia.AbstractPURPOSE OF REVIEW: To evaluate new development in the utility of brain natriuretic peptide and N-Terminal brain natriuretic peptide (BNP/NT-Pro-BNP) in the management of various cardiovascular diseases. The determination of plasma BNP levels has an established role in the discrimination of pulmonary oedema from other causes of acute dyspnoea, and there is increasing evidence of the utility of BNP/NT-Pro-BNP assay both as a prognostic tool in chronic heart failure and as a means of guiding therapy in heart failure patients aged below 70 years.
Current opinion in cardiology.Curr Opin Cardiol.2014 Mar;29(2):160-6. doi: 10.1097/HCO.0000000000000036.
PURPOSE OF REVIEW: To evaluate new development in the utility of brain natriuretic peptide and N-Terminal brain natriuretic peptide (BNP/NT-Pro-BNP) in the management of various cardiovascular diseases. The determination of plasma BNP levels has an established role in the discrimination of pulmonary
PMID 24406448

Incidence and angiographic characteristics of patients With apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: An analysis from a multicenter, international study of ST-elevation myocardial infarction.

Prasad A, Dangas G, Srinivasan M, Yu J, Gersh BJ, Mehran R, Stone GW.Author information Cardiovascular Sciences Research Centre, St. George's, University of London, Cranmer Terrace, London, SW17 0RE, United Kingdom.AbstractObjectives: To determine the incidence, clinical characteristics, and the coronary angiographic features of patients with apical ballooning syndrome (ABS) among those recruited into a large, prospective, international, multicenter trial. Background: ABS is an important entity in the differential diagnosis of ST-elevation myocardial infarction (STEMI). Current data regarding ABS are limited to single center registries. Methods: Patients with ABS were identified, based on the Mayo Clinic diagnostic criteria, from those enrolled into the HORIZONS-AMI trial. Quantitative angiography was performed by a core laboratory to identify the frequency and severity of coronary artery disease. Results: Among the 2,648 patients who had left ventriculography in addition to coronary angiography, 12 patients were identified with ABS. All patients were female and they were compared to the remaining 571 female patients with STEMI. Compared with patients with STEMI (97.9% of our cohort), patients with ABS (2.1%) had a lower prevalence (42% vs. 100%, P < 0.05) and severity (number of plaques measuring >30% diameter stenosis per patient: 0.58 ± 0.90 vs. 4.13 ± 2.68, P < 0.0001) of coronary artery disease. There were no in-hospital deaths or major adverse cardiovascular events (MACE) in the ABS group vs. 2.1% and 3.7% respectively in the STEMI group, nor at 2-year follow up (death: 0% vs. 5.5%, MACE: 0% vs. 19.4%), but these differences were not statistically significant. Conclusions: In HORIZONS-AMI, ABS was identified exclusively in women (2.1% of female patients, 0.5% of all patients) and MACE were absent in this uncommon but important group of patients. Coronary artery disease was often present in patients with ABS, but its prevalence and severity was significantly less compared with STEMI patients. © 2011 Wiley Periodicals, Inc.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.Catheter Cardiovasc Interv.2014 Feb 15;83(3):343-8. doi: 10.1002/ccd.23441. Epub 2013 Oct 21.
Objectives: To determine the incidence, clinical characteristics, and the coronary angiographic features of patients with apical ballooning syndrome (ABS) among those recruited into a large, prospective, international, multicenter trial. Background: ABS is an important entity in the differential dia
PMID 22121008